ProPhase Labs, Inc. Cash And Cash Equivalents At Carrying Value

• ProPhase Labs, Inc. showed a decrease of -57.9% in Cash And Cash Equivalents At Carrying Value from 2023 to 2024.
• This data is from ProPhase Labs, Inc.'s annual report (Form 10-K), filed with the SEC on April 1, 2025.
• XBRL data for this metric is available from 2008 to 2024 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2008 to 2024), ProPhase Labs, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 94.3%.
• Historical annual values: Fiscal year 2024: $678.0 thousand | Fiscal year 2023: $1.61 million | Fiscal year 2022: $9.11 million | Fiscal year 2021: $8.41 million | Fiscal year 2020: $6.82 million | Fiscal year 2019: $434.0 thousand | Fiscal year 2018: $1.55 million | Fiscal year 2017: $3.17 million | Fiscal year 2016: $441.0 thousand | Fiscal year 2015: $1.66 million | Fiscal year 2014: $2.93 million | Fiscal year 2013: $1.64 million | Fiscal year 2012: $572.0 thousand | Fiscal year 2011: $5.54 million | Fiscal year 2010: $8.23 million | Fiscal year 2009: $12.80 million | Fiscal year 2008: $11.96 million.
• Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: June 24, 2026